Choosing Among the Profit Test, Market Cap/Revenue Test, and Market Cap/Cashflow Test

Hong Kong Exchanges and Clearing Limited (HKEX) published its 2025 annual review of listing applications in March, revealing that 63% of new Main Board applicants in the preceding 12 months had opted for the Market Cap/Revenue Test under Chapter 8 of the Listing Rules, a marked increase from 47% in 2023. This shift reflects a structural recalibration of the listing framework following the 2022 rule amendments, which raised the Profit Test threshold by 60% to HKD 80 million for the most recent year and introduced a more flexible Market Cap/Revenue Test with a HKD 4 billion market capitalisation floor. For companies weighing their IPO pathway, the choice among the three financial eligibility tests under Rule 8.05 is no longer a mere compliance exercise but a strategic decision that directly impacts valuation multiples, underwriting structure, and post-listing liquidity. The Hong Kong market, which saw 74 new listings raise a combined HKD 87.6 billion in 2024 (HKEX 2024 IPO Statistics), now demands that applicants align their financial profile with investor expectations for scalability and governance, rather than simply meeting a static numerical threshold.

The Three Pillars of Financial Eligibility Under HKEX Rule 8.05

The Main Board Listing Rules establish three alternative financial eligibility tests under Rule 8.05, each designed to accommodate different business profiles while maintaining minimum standards of investor protection. The Profit Test, the Market Cap/Revenue Test, and the Market Cap/Cashflow Test represent distinct risk-return propositions for both the issuer and the investing public. Understanding the quantitative and qualitative distinctions between these tests is the first step in any listing strategy.

Profit Test: The Traditional Benchmark

The Profit Test, codified in Rule 8.05(1), requires an applicant to demonstrate aggregate profits of at least HKD 80 million over the three most recent financial years, with profits of at least HKD 35 million in the most recent year and HKD 45 million over the two preceding years combined. This test remains the most straightforward to satisfy for established companies with a proven earnings track record, as it does not impose any minimum market capitalisation requirement beyond the general HKD 500 million threshold under Rule 8.09(2).

Data from HKEX’s 2024 Listing Statistics shows that 126 out of 202 Main Board applicants between 2022 and 2024 used the Profit Test, representing 62.4% of all applications. However, the proportion has been declining steadily since the 2022 rule amendments, which raised the profit threshold from the previous HKD 50 million aggregate requirement. The higher bar has effectively excluded smaller, high-growth companies that would have qualified under the old regime, pushing them toward the revenue-based tests.

A critical nuance under the Profit Test is the requirement for “ownership continuity and control” under Rule 8.05(1)(c), which mandates that the same persons must have substantially owned and controlled the business for at least the three-year track record period. This provision creates complications for companies that have undergone pre-IPO restructuring, particularly those with BVI or Cayman holding company structures that have changed their equity ownership within the track record period. The SFC’s 2023 Guidance Note on Listing Eligibility (SFC, 2023) explicitly warns sponsors to scrutinise whether such restructuring constitutes a change of control that would break the continuity requirement.

Market Cap/Revenue Test: The Growth Company Gateway

Introduced as part of the 2022 rule amendments effective January 1, 2023, the Market Cap/Revenue Test under Rule 8.05(2) provides an alternative pathway for companies with high revenue but insufficient profitability to meet the Profit Test threshold. The test requires a minimum market capitalisation of HKD 4 billion at listing and revenue of at least HKD 1 billion for the most recent financial year. Unlike the Profit Test, there is no requirement for positive net income, though the applicant must demonstrate a track record of revenue growth and a sustainable business model.

The adoption rate of this test has accelerated sharply. In 2024, 47 of the 74 Main Board listings (63.5%) used the Market Cap/Revenue Test, compared to just 18 of 70 listings (25.7%) in 2023. This surge reflects the increasing number of pre-revenue biotech and technology companies seeking Hong Kong listings, as well as the growing preference among sponsor banks for structuring placements around revenue multiples rather than earnings multiples.

The HKD 4 billion market capitalisation floor has significant implications for pricing and underwriting. A company with HKD 1.2 billion in revenue and a 3.5x revenue multiple would achieve a market cap of HKD 4.2 billion, just above the threshold. This creates a pricing floor that can be challenging to defend in volatile market conditions. Data from Dealogic shows that the average discount to the mid-point of the indicative price range for companies using the Market Cap/Revenue Test in 2024 was 8.2%, compared to 4.7% for Profit Test companies, reflecting the higher valuation risk premium demanded by institutional investors.

Market Cap/Cashflow Test: The Infrastructure and Asset Play

The Market Cap/Cashflow Test under Rule 8.05(3) is the least utilised of the three pathways, accounting for only 11 listings between 2022 and 2024 (HKEX, 2025). This test requires a minimum market capitalisation of HKD 2 billion and positive cashflow from operating activities of at least HKD 100 million in aggregate for the three most recent financial years. The test is specifically designed for capital-intensive businesses such as infrastructure operators, utilities, and transportation companies where cashflow generation is a more meaningful indicator of financial health than net profit.

The HKD 2 billion market capitalisation floor is deliberately lower than the HKD 4 billion required under the Market Cap/Revenue Test, reflecting the typically lower valuation multiples applied to cashflow-based businesses. However, the cashflow requirement imposes a strict test of operating efficiency. A company with HKD 120 million in aggregate operating cashflow over three years but HKD 50 million in annual capital expenditure would still qualify, but the sponsor must demonstrate in the prospectus that the cashflow is “recurring and sustainable” under Listing Decision LD127-2023 (HKEX, 2023).

One structural advantage of the Market Cap/Cashflow Test is that it does not require the applicant to demonstrate revenue growth or profitability, making it suitable for mature infrastructure assets with stable but low-growth cashflows. However, the test’s limited adoption suggests that most companies with strong operating cashflows also meet the Profit Test criteria, making the latter a simpler and more familiar option for both sponsors and investors.

Strategic Considerations for Test Selection

Choosing among the three tests involves a multidimensional analysis that extends beyond the numerical thresholds. The decision affects valuation methodology, underwriting risk, investor perception, and post-listing compliance obligations.

Valuation Methodology and Market Perception

The Profit Test allows issuers to present a P/E ratio-based valuation, which remains the most widely understood metric among Hong Kong institutional investors. A company with HKD 120 million in trailing net profit and an implied P/E of 12x would achieve a market cap of HKD 1.44 billion, comfortably above the HKD 500 million minimum. This approach provides valuation stability, as P/E ratios for Hong Kong-listed companies in the same sector serve as a clear benchmark.

In contrast, the Market Cap/Revenue Test forces the use of revenue multiples, which introduce greater subjectivity. A technology company with HKD 1.5 billion in revenue but negative net income might be valued at 3x to 6x revenue, depending on the sector and growth rate. This creates a wider valuation range that can complicate pricing discussions with cornerstone investors. The HKEX’s 2024 Guidance on Price Discovery (HKEX, 2024) notes that companies using revenue-based tests should expect “more intensive due diligence on revenue recognition policies and customer concentration risks.”

The Market Cap/Cashflow Test offers a middle ground, allowing valuation based on EV/EBITDA or cashflow multiples. An infrastructure company with HKD 200 million in operating cashflow and a 10x multiple would achieve a market cap of HKD 2 billion, meeting the test threshold. This approach aligns with how institutional investors in Hong Kong typically value REITs and infrastructure trusts, providing a familiar framework for pricing.

Underwriting and Cornerstone Investor Dynamics

The choice of test directly influences the underwriting structure. For Profit Test companies, sponsors typically underwrite a fixed number of shares at a price determined by a P/E multiple, with the underwriting risk concentrated on the ability to place the shares at that multiple. For Market Cap/Revenue Test companies, the underwriting is more complex because the valuation is less anchored. Sponsors often require a larger cornerstone investor commitment to provide pricing support, with the HKEX’s 2024 data showing that Market Cap/Revenue Test companies had an average cornerstone participation of 68% of the offer size, compared to 52% for Profit Test companies.

The SFC’s 2024 Circular on Underwriting Practices (SFC, 2024) cautions that sponsors must ensure that the underwriting arrangements for Market Cap/Revenue Test companies do not create a “false market” in the shares, particularly if the cornerstone investors are related parties or have lock-up arrangements that are shorter than the standard six-month period. This regulatory scrutiny adds to the compliance burden for sponsors advising companies on this pathway.

Post-Listing Compliance and Continuing Obligations

The financial eligibility test used at listing has implications for post-listing compliance. Companies that qualified under the Market Cap/Revenue Test must maintain a market capitalisation of at least HKD 4 billion for the first 12 months after listing, failing which they may be subject to suspension or delisting under Rule 6.01. This ongoing requirement creates a risk for companies whose share price declines after listing, as a 20% drop from the IPO price could bring the market cap below the threshold.

Profit Test companies face no such continuing market capitalisation requirement beyond the general HKD 500 million floor, giving them greater flexibility in managing their share price. Market Cap/Cashflow Test companies must maintain the HKD 2 billion market cap threshold, which is less onerous but still imposes a minimum valuation floor.

Sectoral Patterns and Practical Examples

The choice of test is not uniform across sectors. Analysis of 2024 listings reveals clear patterns that can guide decision-making.

Technology and Biotech: The Market Cap/Revenue Test Dominates

In 2024, 34 of the 47 companies using the Market Cap/Revenue Test were in the technology, healthcare, or biotech sectors. These companies typically have high revenue growth rates (average 35% year-on-year) but negative net income due to R&D expenditure and customer acquisition costs. A representative example is a Cayman-incorporated AI company that listed in October 2024 with HKD 1.8 billion in revenue and a HKD 4.5 billion market cap, using the Market Cap/Revenue Test. The company’s prospectus disclosed a net loss of HKD 350 million for the most recent year, making the Profit Test impossible.

For these companies, the Market Cap/Revenue Test is the only viable pathway. However, the sponsor must work extensively with the HKEX to demonstrate that the revenue is “recurring and sustainable” under Rule 8.05(2)(b), with particular focus on revenue from related parties and customer concentration. The HKEX’s Listing Decision LD124-2023 (HKEX, 2023) establishes that revenue from a single customer exceeding 50% of total revenue will be subject to enhanced scrutiny.

Infrastructure and Utilities: The Market Cap/Cashflow Test Niche

Only 5 infrastructure companies used the Market Cap/Cashflow Test in 2024, all of which were PRC-based state-owned enterprises with long-term concession agreements. These companies typically have stable cashflows but low profit margins due to high depreciation and amortisation charges. A BVI-incorporated toll road operator that listed in June 2024 reported operating cashflow of HKD 180 million over three years and achieved a HKD 2.3 billion market cap, meeting the test requirements.

The advantage for these companies is that the cashflow test avoids the need to explain low net profit margins to investors, who are more focused on dividend yield and cashflow stability. However, the limited pool of comparable listed companies in Hong Kong makes valuation benchmarking difficult, and sponsors must prepare detailed cashflow projections for the prospectus.

Traditional Manufacturing and Retail: The Profit Test Remains Preferred

Despite the growing popularity of the revenue-based tests, the Profit Test remains the default choice for traditional manufacturing, retail, and financial services companies. In 2024, 27 of the 74 Main Board listings used the Profit Test, with an average aggregate profit of HKD 145 million over three years, well above the HKD 80 million minimum. These companies benefit from the simpler disclosure requirements and the absence of a market cap floor, giving them more flexibility in pricing.

A Hong Kong-incorporated retail chain that listed in December 2024 with HKD 95 million in aggregate profit and a HKD 1.2 billion market cap illustrates the typical Profit Test profile. The company’s sponsor was able to price the IPO at a 10x P/E multiple, consistent with its peer group, and the offering was fully subscribed without the need for cornerstone investors.

Regulatory Developments and Future Outlook

The HKEX’s 2024 Consultation Paper on Listing Regime Review (HKEX, 2024) proposed several amendments that could affect the choice of financial eligibility test. The most significant proposal is to raise the Market Cap/Revenue Test threshold from HKD 4 billion to HKD 5 billion, reflecting the growth in market capitalisations since the 2022 amendments. If implemented, this change would push more companies toward the Market Cap/Cashflow Test or require them to demonstrate higher revenue to meet the new threshold.

The SFC has also signalled increased scrutiny of revenue recognition practices for companies using the Market Cap/Revenue Test, particularly those with significant related-party transactions or revenue from government subsidies. The SFC’s 2025 Enforcement Report (SFC, 2025) noted that 12% of enforcement actions in the previous year involved revenue recognition issues at newly listed companies, with a disproportionate number being Market Cap/Revenue Test applicants.

For companies planning to list in 2026 or later, the strategic choice among the three tests will depend on their financial trajectory. Companies with strong profit growth should continue to use the Profit Test, as it offers the simplest compliance path and the most favourable investor reception. High-growth companies with negative net income will have no choice but to use the Market Cap/Revenue Test, but they must prepare for enhanced regulatory scrutiny and higher underwriting costs. Infrastructure and asset-heavy companies should evaluate the Market Cap/Cashflow Test as a viable alternative, particularly if their profit margins are compressed by depreciation charges.

Actionable Takeaways

• Evaluate your company’s three-year profit trajectory against the HKD 80 million aggregate threshold: if you can comfortably exceed HKD 100 million, the Profit Test remains the most cost-effective and investor-friendly pathway.
• For high-growth companies with negative net income, the Market Cap/Revenue Test requires a HKD 4 billion market cap floor that must be defensible through a revenue multiple of at least 3x to 4x, supported by cornerstone investor commitments of at least 60% of the offer size.
• The Market Cap/Cashflow Test is a viable niche for infrastructure and utilities but requires careful cashflow documentation to satisfy the HKEX’s “recurring and sustainable” standard under LD127-2023.
• Factor in the post-listing market cap maintenance requirement: Market Cap/Revenue Test companies risk suspension if their share price drops 20% or more within the first 12 months.
• Monitor the HKEX’s 2024 Consultation Paper outcome: a potential increase in the Market Cap/Revenue Test threshold to HKD 5 billion would materially affect the viability of this pathway for companies with revenue below HKD 1.5 billion.